INTRODUCTION
Sensitive skin (SS) is a common, subjective syndrome of cutaneous hyperreactivity. Despite having an estimated global prevalence between 40% and 70%,1 no consistent guidelines exist to guide dermatologists' approaches to diagnosis, management, or counseling of patients with a complaint of SS. Given the current ambiguity of management principles, we sought to gauge dermatology providers' experiences and perspectives on SS through a survey of attendees at an international dermatology conference.
MATERIALS AND METHODS
Sensitive skin (SS) is a common, subjective syndrome of cutaneous hyperreactivity. Despite having an estimated global prevalence between 40% and 70%,1 no consistent guidelines exist to guide dermatologists' approaches to diagnosis, management, or counseling of patients with a complaint of SS. Given the current ambiguity of management principles, we sought to gauge dermatology providers' experiences and perspectives on SS through a survey of attendees at an international dermatology conference.
Attendees of the 2022 European Academy of Dermatology and Venereology Congress completed live polls throughout an educational session on SS. Attendees were predominantly dermatologists, a minority (estimated 8-10%) were other dermatology providers including nurses. All questions were multiple choice and required individuals to select one best answer. Survey is IRB exempt (#NCR224549) and no personal data were collected from respondents. The actual number of respondents differed slightly per question, as data were obtained from live polls voluntarily completed by audience members. Response rates per question ranged from 71 to 100%. The total number of respondents that completed each question is indicated below. Results were compiled for analysis.
RESULTS
Fifty-one percent of surveyed dermatology providers estimated the prevalence of SS to be between 25% and 49% (n=45). An additional 34% estimated SS prevalence to be 50% to 74%, while a minority of respondents estimated less than 25% or greater than 75% (13% and 2%, respectively). When asked to approximate the number of clinic patients per week presenting to their office with a complaint of SS (n=41), selections ranged from fewer than 10 patients per week to greater than 50, with respondents most commonly reporting 10 to 20 patients weekly (44%; Figure 1). Surveyed providers (n=36) considered the primary symptom of SS to be redness (41%), burning (14%), stinging (25%), pruritus (17%), or tingling (3%). When prompted to choose the most likely etiology for SS (n=32), 72% indicated that altered skin barrier is the main cause of SS. Other selected options included external or environmental factors (16%), primary neuropathy (6%), and immune dysregulation (6%). No respondents classified SS as a result or symptom of 
